Cao, Y., Li, R., Wang, S., Ma, J., Ji, Y., Lin, C., Du, P. (2025). Changes in circulating tumor cells (CTCs) and HER2 expression in evaluating the efficacy of neoadjuvant disitamab vedotin plus toripalimab treatment in patients with muscle-invasive bladder cancer (MIBC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.837